Verition Fund Management
BNTX icon

Verition Fund Management’s BioNTech BNTX Stock Holding History

Verition Fund Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,600
Closed -$438K – 2397
2025
Q4 		$438K Sell
4,600
-14,800
-76% -$1.49M ﹤0.01% 2766
2025
Q3 		$1.91M Buy
19,400
+11,400
+143% +$1.22M 0.01% 2021
2025
Q2 		$852K Buy
+8,000
New +$808K ﹤0.01% 2585

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Verition Fund Management's BNTX Position: Q1 2026 in Review

Verition Fund Management reduced its BioNTech (BNTX) stake by 32% in Q1 2026, selling an estimated $243K and leaving 5,126 shares worth $456K. The position accounts for ﹤0.01% of the portfolio, ranked #1621.

Verition Fund Management first reported a position in BNTX in Q4 2020 and has held it in 6 quarters since. The position peaked at $1.93M in Q4 2024. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Verition Fund Management held 5,126 shares of BioNTech worth $456K as of Q1 2026.
  • Verition Fund Management sold 2,364 BioNTech shares in Q1 2026, an estimated $243K.
  • BioNTech made up ﹤0.01% of Verition Fund Management's portfolio in Q1 2026, its #1621 holding.
  • Verition Fund Management first reported a position in BioNTech in Q4 2020 and has held it in 6 quarters since.
  • Verition Fund Management's BioNTech position peaked at $1.93M in Q4 2024.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.